Dow Up0.25% Nasdaq Up0.65%

Emergent BioSolutions, Inc. (EBS)

-NYSE
43.70 Up 0.55(1.27%) May 27, 4:02PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
Total Revenue 522,789   450,138   312,745  
Cost of Revenue124,295  118,412  62,127  
Gross Profit 398,494   331,726   250,618  
Operating Expenses
Research Development153,997  150,829  119,933  
Selling General and Administrative148,458  122,841  87,883  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 96,039   58,056   42,802  
Income from Continuing Operations
Total Other Income/Expenses Net253  3,246  565  
Earnings Before Interest And Taxes96,292  61,302  43,367  
Interest Expense6,523  8,240   -  
Income Before Tax89,769  53,062  43,367  
Income Tax Expense26,899  16,321  13,108  
Minority Interest -   -  876  
Net Income From Continuing Ops62,870  36,741  31,135  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 62,870   36,741   31,135  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 62,870   36,741   31,135  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.